Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
32,343,237
-
Shares change
-
+266,759
-
Total reported value, excl. options
-
$237,397,127
-
Value change
-
+$913,474
-
Put/Call ratio
-
18%
-
Number of buys
-
31
-
Number of sells
-
38
-
Price
-
$7.34
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2018
As of 31 Mar 2018 Seres Therapeutics, Inc. - COMMON STOCK (MCRB) had 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,343,237 shares of stock of the company.
Largest 10 holders included Flagship Pioneering Inc., FMR LLC, ARK Investment Management LLC, BlackRock Inc., FEDERATED INVESTORS INC /PA/, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Capital World Investors, JPMORGAN CHASE & CO, and STATE STREET CORP.
This table shows 76 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.